By browsing our site you agree to our use of cookies. You will only see this message once. Find out more

Supply and Delivery of Radiology Consumables.

Modification notice

Modification of a contract/concession during its term

Directive 2014/24/EU

Section I: Contracting authority/entity

I.1)Name and addresses
Procurement and Logistics Service
16 College Street
Belfast
BT1 6BT
United Kingdom
Contact person: Laura Perry
Telephone: +44 02895361516
E-mail:
NUTS code: UKN01

Internet address(es):

Main address: www.hscbusiness.hscni.net

Section II: Object

II.1)Scope of the procurement
II.1.1)Title:

Interventional Radiology Products.

Reference number: 8019
II.1.2)Main CPV code
33111600
II.1.3)Type of contract
Supplies
II.2)Description
II.2.1)Title:
II.2.2)Additional CPV code(s)
II.2.3)Place of performance
NUTS code: UKN01
II.2.4)Description of the procurement at the time of conclusion of the contract:

Supply and Delivery of Radiology Consumables.

II.2.7)Duration of the contract, framework agreement, dynamic purchasing system or concession
Duration in months: 48
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no

Section IV: Procedure

IV.2)Administrative information
IV.2.1)Contract award notice concerning this contract
Notice number in the OJ S: 2013/S 079-132272

Section V: Award of contract/concession

Contract No: 8019
Title:

Interventional Radiology Consumables

V.2)Award of contract/concession
V.2.1)Date of conclusion of the contract/concession award decision:
13/03/2013
V.2.2)Information about tenders
The contract/concession has been awarded to a group of economic operators: yes
V.2.3)Name and address of the contractor/concessionaire
As per contract award notice
Belfast
United Kingdom
NUTS code: UKN01
The contractor/concessionaire is an SME: no
V.2.3)Name and address of the contractor/concessionaire
As per contract award notice
Belfast
United Kingdom
NUTS code: UKN01
The contractor/concessionaire is an SME: no
V.2.4)Information on value of the contract/lot/concession (at the time of conclusion of the contract;excluding VAT)
Total value of the procurement: 16 000 000.00 GBP

Section VI: Complementary information

VI.3)Additional information:
VI.4)Procedures for review
VI.4.1)Review body
Business Services Organisation
Belfast
United Kingdom
VI.4.2)Body responsible for mediation procedures
VI.4.3)Review procedure
VI.4.4)Service from which information about the review procedure may be obtained
VI.5)Date of dispatch of this notice:
15/03/2017

Section VII: Modifications to the contract/concession

VII.1)Description of the procurement after the modifications
VII.1.1)Main CPV code
33111600
VII.1.2)Additional CPV code(s)
VII.1.3)Place of performance
NUTS code: UKN01
VII.1.4)Description of the procurement:

Interventional Radiology Consumables.

VII.1.5)Duration of the contract, framework agreement, dynamic purchasing system or concession
Duration in months: 48
VII.1.6)Information on value of the contract/lot/concession (excluding VAT)
Total value of the contract/lot/concession: 18 300 000.00 GBP
VII.1.7)Name and address of the contractor/concessionaire
As per contract award notice
Belfast
United Kingdom
NUTS code: UKN01
The contractor/concessionaire is an SME: no
VII.1.7)Name and address of the contractor/concessionaire
As per contract award notice
Belfast
United Kingdom
NUTS code: UKN01
The contractor/concessionaire is an SME: no
VII.2)Information about modifications
VII.2.1)Description of the modifications
Nature and extent of the modifications (with indication of possible earlier changes to the contract):

There has been an unforeseen surge in usage on this framework that could not have been predicted. Increase is approximately 3.39 % of the overall contract award value and as such this modification does not represent a material change to the contract. The current framework expires on 31.3.2017 with a new framework due to start on 1.4.2017 therefore the period of this modification is 3 weeks. The work of removing the contract from the purchase to pay system, loading an interim solution and loading the replacement framework would cause significant inconvenience and substantial duplication of costs. This would lead to a significant risk of negative clinical impact and the associated impact on patient care.

VII.2.2)Reasons for modification
Need for modification brought about by circumstances which a diligent contracting authority/entity could not foresee (Art. 43(1)(c) of Directive 2014/23/EU, Art. 72(1)(c) of Directive 2014/24/EU, Art. 89(1)(c) of Directive 2014/25/EU)
Description of the circumstances which rendered the modification necessary and explanation of the unforeseen nature of these circumstances:

There has been an unforeseen surge in usage on this framework that could not have been predicted. Increase is approximately 3.39 % of the overall contract award value and as such this modification does not represent a material change to the contract. The current framework expires on 31.3.2017 with a new framework due to start on 1.4.2017 therefore the period of this modification is 3 weeks. The work of removing the contract from the purchase to pay system, loading an interim solution and loading the replacement framework would cause significant inconvenience and substantial duplication of costs. This would lead to a significant risk of negative clinical impact and the associated impact on patient care.

VII.2.3)Increase in price
Updated total contract value before the modifications (taking into account possible earlier contract modifications and price adaptions and, in the case of Directive 2014/23/EU, average inflation in the Member State concerned)
Value excluding VAT: 16 000 000.00 GBP
Total contract value after the modifications
Value excluding VAT: 18 300 000.00 GBP